The Patent Finder

Terms ending in 2036

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,300,065Method of Treating or Prevention of Atherothrombotic Events in Patients with History of Myocardial Infarction
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,954,308Antibodies to Ticagrelor and Methods of Use
In force
 · Medium confidence
MedImmune LimitedIn forceMedium confidence
US 9,982,061Antibodies to Ticagrelor and Methods of Use
In force
 · High confidence
MedImmune LimitedIn forceHigh confidence
US 10,183,947Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,508,119Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,001,589Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,691,978Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,024,523Pyrazole Derivatives Useful as 5-Lipoxygenase Activating Protein (FLAP) Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,845,331Chemical Compounds
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,717,746Chemical Compounds
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
24 more term ends in 2036 · Pro
10 of 34 patents shown. Soonest term end first, then patent number.
Pro members see all 34.
Upgrade to Pro
26 of these are in force and held by AstraZeneca AB.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited